Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies

Innovations in Management

Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies

Innovations in Management

106,99 €*

lieferbar in ca. 2-4 Werktagen

Falls Sie eine Lieferung außerhalb DE, AT oder CH wünschen, nutzen Sie bitte unser Kontaktformular für eine Anfrage.

In the United States in 1997, 28800 new cases of malignant tumors of the kidney and renal pelvis were diagnosed along with 2100 new cases of malignant tumors of the ureter and other urinary organs, 7200 primary malignant tumors of the testis, and 1300 primary malignant tumors of the penis and other genital organs. In large measure, surgery is the treatment of choice for these tumors, but radiation therapy is in creasingly recognized as having significant and important curative and palliative bene fits in each of these tumor sites. Surgery is the standard form of treatment for non metastatic renal cell carcinomas as well as for malignancies of the renal pelvis and ureter, with radical nephrectomy and radical uretectomy being employed. However, postoperative radiation therapy is of value for those patients who demonstrate evi dence of residual tumor following surgery, transection of tumor during surgery, or positive regional lymph node drainage. As regards the rare tumors that involve the female urethra, surgical resection is appropriate for those that are limited and local in character and amenable to partial ureterectomy. With tumors that are more advanced in character, however, local recurrence and lymphatic dissemination are significant problems, and treatmentby radiation therapy programs alone yield satisfactory control rates as well as limited recurrences and long-term survivors. For primary tumors involving the testis, the major approach to nonseminomatous tumors is surgical resection with postsurgical systemic chemotherapy.

Renal Cell Carcinoma
1 Epidemiology of Renal Cell Carcinoma
2 Pathology of Renal Cell Carcinoma
3 Genetics of Renal Cell Carcinoma
4 Imaging of Renal Parenchymal Tumors
5 Radical Nephrectomy
6 Nephron-Sparing Surgery
7 Palliative Surgical Therapy
8 Preoperative and Palliative Embolization
9 Immunotherapy and Chemotherapy for Metastatic Renal Cell Carcinoma
10 The Role of Radiotherapy in the Management of Patients with Renal Cell Carcinoma
11 Radiation Therapy for Carcinoma of the Renal Pelvis and Ureters
12 Diagnosis and Management of Tumors of the Adrenal Gland
13 Surgical Treatment of Adrenal Gland Tumors
14 Diagnosis and Management of Retroperitoneal Tumors in Pediatric Patients
Carcinoma of the Testis CAR
15 Carcinoma of the Testis: The Epidemiology and Etiology
16 Carcinoma of the Testis: Pathology
17 Imaging of Testicular Neoplasms
18 Surgical Treatment for Early Germ Cell Tumors
19 Surgery for Advanced Stage Testis Cancer
20 Radiotherapy in Early Seminoma
21 Radiotherapy for Bulky Seminoma
22 Radiotherapy of Testicular Germ Cell Tumors: The German Experience
23 Chemotherapy for Seminoma
24 Nonseminomatous Germ Cell Tumors
25 Is a Policy of Surveillance Warranted in Early Stage Testicular Cancer Following Orchiectomy?
26 Fertility Following Treatment of Testicular Carcinoma
27 Testicular Tumors in Prepubertal Boys: Assessment and Treatment
Carcinoma of the Penis and Scrotum
28 Surgical Management of Carcinoma of the Penis and Scrotum
29 Radiotherapy in Cancer of the Penis, Male Urethra, and Scrotum
Carcinoma of the Female Urethra
30 Urethral Carcinoma of the Female Urethra: Surgical Management
31 Radiation Therapy for the Female Urethra
Sarcoma of the Genito-Urinary Tract in Adults
32 PrimaryRetroperitoneal Sarcomas
33 Adult Genitourinary Sarcomas: Pelvic Sarcomas
34 Hematologic Malignancies Involving the Genitourinary System
35 Rhabdomyosarcoma of the Genitourinary Tract in Pediatric Patients
36 Measures to Optimize Quality of Life in Patients Treated for Genitourinary Tumors
37 Racial Differences in the Incidence, Behavior, and Management of Tumors of the Genitourinary Tract
38 Risk of Second Malignancies Following Treatment for Genitourinary Tumors
List of Contributors.
ISBN 9783642641442
Artikelnummer 9783642641442
Medientyp Buch
Auflage Softcover reprint of the original 1st ed. 1999
Copyrightjahr 2011
Verlag Springer, Berlin
Umfang 472 Seiten
Abbildungen XIII, 472 p. 40 illus. in color.
Sprache Englisch